These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8375267)

  • 1. Bovine and human NPH insulins as T cell immunogens.
    Gregory R; Tattersall RB
    Diabetes Res Clin Pract; 1993 May; 20(2):139-46. PubMed ID: 8375267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
    Kurtz AB; Gray RS; Markanday S; Nabarro JD
    Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine antibody production in diabetic subjects treated with NPH insulin.
    Ellerhorst JA; Comstock JP; Nell LJ
    Am J Med Sci; 1990 May; 299(5):298-301. PubMed ID: 2337121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of NPH human insulin (recombinant DNA) and NPH bovine insulin in diabetic subjects.
    Marre M; Tabbi-Anneni A; Tabbi-Anneni H; Assan R
    Diabetes Care; 1982; 5 Suppl 2():63-6. PubMed ID: 6765544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
    Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals.
    Sailer D; Ludwig T; Kolb S
    Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
    Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
    J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.
    Stewart WJ; McSweeney SM; Kellett MA; Faxon DP; Ryan TJ
    Circulation; 1984 Nov; 70(5):788-92. PubMed ID: 6488493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.
    Frier BM; Russell-Jones D; Heise T
    Diabetes Obes Metab; 2013 Nov; 15(11):978-86. PubMed ID: 23551900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protamine allergy reactions during cardiac catheterization and cardiac surgery: risk in patients taking protamine-insulin preparations.
    Vincent GM; Janowski M; Menlove R
    Cathet Cardiovasc Diagn; 1991 Jul; 23(3):164-8. PubMed ID: 1831070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes.
    Monetini L; Barone F; Stefanini L; Petrone A; Walk T; Jung G; Thorpe R; Pozzilli P; Cavallo MG
    J Endocrinol; 2003 Jan; 176(1):143-50. PubMed ID: 12525258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of semisynthetic human NPH insulin and porcine NPH insulin in the treatment of insulin-dependent diabetes mellitus.
    Pedersen C; Høegholm A
    Diabet Med; 1987; 4(4):304-6. PubMed ID: 2956040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin.
    Dykewicz MS; Kim HW; Orfan N; Yoo TJ; Lieberman P
    J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):117-25. PubMed ID: 8308177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes.
    Witthaus E; Stewart J; Bradley C
    Diabet Med; 2001 Aug; 18(8):619-25. PubMed ID: 11553198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of NPH human insulin (recombinant DNA) and pork insulin in diabetic subjects: preliminary report.
    Mirouze J; Monnier L; Richard JL; Gancel A; Soua KB
    Diabetes Care; 1982; 5 Suppl 2():60-2. PubMed ID: 6765543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T
    Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.
    Harrison LC; De Aizpurua H; Loudovaris T; Campbell IL; Cebon JS; Tait BD; Colman PG
    Diabetes; 1991 Sep; 40(9):1128-33. PubMed ID: 1936620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protamine allergy as a complication of insulin hypersensitivity: A case report.
    Bollinger ME; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):462-5. PubMed ID: 10452772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.